Cite
APA Citation
Alqahtani, S. A., Afdhal, N., Zeuzem, S., Gordon, S. C., Mangia, A., Kwo, P., Fried, M., Yang, J. C., Ding, X., Pang, P. S., McHutchison, J. G., Pound, D., Reddy, K. R., Marcellin, P., Kowdley, K. V., & Sulkowski, M. (n.d.). safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials. Hepatology, 62(1), 25–30. http://access.bl.uk/ark:/81055/vdc_100160976085.0x00004a